Benzofuran sulfonates and small self-lipid antigens activate type II NKT cells via CD1d
| Autor: | Tu Nguyen, T. Hilmenyuk, Catarina F. Almeida, Christopher M. Harpur, Tan-Yun Cheng, Spencer J. Williams, Adam P Uldrich, I van Rhijn, E. Batleska, Daniel G. Pellicci, B. Moody, Jamie Rossjohn, Dale I. Godfrey, Catriona V. Nguyen-Robertson, Sjj Reddiex, David J. Smith |
|---|---|
| Přispěvatelé: | Immunologie, dI&I RA-I&I I&I |
| Rok vydání: | 2021 |
| Předmět: |
T cell
Cell Population chemical and pharmacologic phenomena CD1d 03 medical and health sciences 0302 clinical medicine Antigen medicine General education Receptor 030304 developmental biology 0303 health sciences education.field_of_study biology Chemistry T-cell receptor hemic and immune systems Natural killer T cell Cell biology medicine.anatomical_structure CD1D biology.protein Type II NKT lipids (amino acids peptides and proteins) PPBF TCR 030215 immunology |
| DOI: | 10.1101/2021.03.05.433980 |
| Popis: | Natural Killer T (NKT) cells detect lipids presented by CD1d. Most studies focus on type I NKT cells that express semi-invariant αβ T cell receptors (TCR) and recognise α-galactosylceramides. However, CD1d also presents structurally distinct lipids to NKT cells expressing diverse TCRs (type II NKT cells) but our knowledge of the antigens for type II NKT cells is limited. An early study identified an NKT cell agonist, phenyl pentamethyldihydrobenzofuransulfonate (PPBF), which is notable for its similarity to common sulfa-drugs, but its mechanism of NKT-cell activation remained unknown. Here we demonstrate that a range of pentamethylbenzofuransulfonate (PBFs), including PPBF, activate polyclonal type II NKT cells from human donors. Whereas these sulfa drug-like molecules might have acted pharmacologically on cells, here we demonstrate direct contact between TCRs and PBF-treated CD1d complexes. Further, PBF-treated CD1d-tetramers identified type II NKT cell populations cells expressing αβ and γδTCRs, including those with variable and joining region gene usage (TRAV12-1–TRAJ6) that was conserved across donors. By trapping a CD1d-type II NKT TCR complex for direct mass spectrometric analysis, we detected molecules that allow binding of CD1d to TCRs, finding that both PBF and short-chain sphingomyelin lipids are present in these complexes. Furthermore, the combination of PPBF and short-chain sphingomyelin enhances CD1d tetramer staining of PPBF-reactive T cell lines over either molecule alone. This study demonstrates that non-lipidic small molecules, that resemble sulfa-drugs implicated in systemic hypersensitivity and drug allergy reactions, activate a polyclonal population of type II NKT cells in a CD1d-restricted manner.Significance StatementWhereas T cells are known to recognize peptide, vitamin B metabolite or lipid antigens, we identify several non-lipidic small molecules, pentamethylbenzofuransulfonates (PBFs), that activate a population of CD1d-restricted NKT cells. This represents a breakthrough in the field of NKT cell biology. This study also reveals a previously unknown population of PBF-reactive NKT cells in healthy individuals with stereotyped receptors that paves the way for future studies of the role of these cells in immunity, including sulfa-drug hypersensitivity. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|